FlutiForm HFA MDI 250/10 µg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FlutiForm HFA MDI 250/10 µg, covering 2011-06-23 to 2011-06-23. Get the full timeline:
Most recent: Clinical Trial Update: New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma [Phase 3]